Center for Cell Engineering Ninth Annual Retreat Slideshow

Center for Cell Engineering 2017 Retreat Speakers (from left to right) Katy Rezvani (University of Texas MD Anderson Cancer Center), Jeffrey Miller (University of Minnesota), Michel Sadelain, Katharine Hsu, Dan Kaufman (University of California San Diego), Joseph Sun.
Center for Cell Engineering 2017 Retreat Speakers (from left to right) Katy Rezvani (University of Texas MD Anderson Cancer Center), Jeffrey Miller (University of Minnesota), Michel Sadelain, Katharine Hsu, Dan Kaufman (University of California San Diego), Joseph Sun.
Michel Sadelain, Director, Center for Cell Engineering at Sloan Kettering Institute delivers opening remarks.
Michel Sadelain, Director, Center for Cell Engineering at Sloan Kettering Institute delivers opening remarks.
Joseph Sun of Sloan Kettering Institutes Immunology Program, Moderator.
Joseph Sun of Sloan Kettering Institutes Immunology Program, Moderator.
Katharine Hsu of Memorial Sloan Kettering’s Department of Medicine and Center for Cell Engineering presents, “Harnessing NK effects in vivo against solid and hematologic cancers”
Katharine Hsu of Memorial Sloan Kettering’s Department of Medicine and Center for Cell Engineering presents, “Harnessing NK effects in vivo against solid and hematologic cancers”
Jeffrey Miller of the University of Minnesota presents, “Novel Ways to Activate and Target NK cells to Treat Cancer”
Jeffrey Miller of the University of Minnesota presents, “Novel Ways to Activate and Target NK cells to Treat Cancer”
Katy Rezvani of the University of Texas MD Anderson Cancer Center presents, “Genetically engineered cord blood NK cells as an off-the-shelf source of immunotherapy for cancer”
Katy Rezvani of the University of Texas MD Anderson Cancer Center presents, “Genetically engineered cord blood NK cells as an off-the-shelf source of immunotherapy for cancer”
Dan Kaufman of the University of California San Diego presents, “NK cell therapies derived from human pluripotent stem cells”
Dan Kaufman of the University of California San Diego presents, “NK cell therapies derived from human pluripotent stem cells”
Audience.
Audience.